CO2020005768A2 - Phytoconcentrated composition and its uses - Google Patents

Phytoconcentrated composition and its uses

Info

Publication number
CO2020005768A2
CO2020005768A2 CONC2020/0005768A CO2020005768A CO2020005768A2 CO 2020005768 A2 CO2020005768 A2 CO 2020005768A2 CO 2020005768 A CO2020005768 A CO 2020005768A CO 2020005768 A2 CO2020005768 A2 CO 2020005768A2
Authority
CO
Colombia
Prior art keywords
composition
phytoconcentrated
sedative
antidepressant
calming
Prior art date
Application number
CONC2020/0005768A
Other languages
Spanish (es)
Inventor
Gérard N'guyen
Original Assignee
Nguyen Gerard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nguyen Gerard filed Critical Nguyen Gerard
Publication of CO2020005768A2 publication Critical patent/CO2020005768A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)

Abstract

Composición sólida de tipo confitería o de tipo farmacéutica, por ejemplo, bajo forma de pastillas, cápsulas, gránulos o tabletas, que contiene aceite esencial de Cannabis y un soporte a base de azúcar. Semejantes preparaciones brindan a su consumidor una sensación de bienestar que proviene de sus propiedades relajantes, calmantes, sedativas, antiinflamatorias, antidepresivas y analgésicas.Solid composition of the confectionery or pharmaceutical type, for example, in the form of pills, capsules, granules or tablets, containing Cannabis essential oil and a sugar-based support. Such preparations provide its consumer with a feeling of well-being that comes from its relaxing, calming, sedative, anti-inflammatory, antidepressant and analgesic properties.

CONC2020/0005768A 2017-10-12 2020-05-12 Phytoconcentrated composition and its uses CO2020005768A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1759583 2017-10-12
PCT/FR2018/000233 WO2019073127A2 (en) 2017-10-12 2018-10-08 Phyto-concentrated composition and uses thereof

Publications (1)

Publication Number Publication Date
CO2020005768A2 true CO2020005768A2 (en) 2020-07-31

Family

ID=65818034

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2020/0005768A CO2020005768A2 (en) 2017-10-12 2020-05-12 Phytoconcentrated composition and its uses

Country Status (2)

Country Link
CO (1) CO2020005768A2 (en)
WO (1) WO2019073127A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022543584A (en) * 2019-07-29 2022-10-13 ブライトシード・インコーポレイテッド Methods for Improving Digestive Health
EP4098254A1 (en) * 2021-06-04 2022-12-07 Assistance Publique, Hopitaux De Paris Cannabidiol for use in the treatment of pain resulting from an indoleamine 2,3-dioxygenase-1 (ido1) related disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695661A5 (en) * 2001-03-06 2006-07-31 Forsch Hiscia Ver Fuer Krebsfo Pharmaceutical composition.
FR2973706B1 (en) 2011-04-06 2016-05-20 Guyen Gerard Duc N ESSENTIAL PHYTO-CONCENTRATE COMPOSITION ANTISPASMODIC DISCOVERY AND MUSCLE COMFORT
CN103082275A (en) * 2011-10-28 2013-05-08 冯松平 Special female beverage effervescent tablets
US9763991B2 (en) 2013-06-13 2017-09-19 Cannabis Science International Holding B.V. Composition for the treatment of neurobehavioral disorders

Also Published As

Publication number Publication date
WO2019073127A2 (en) 2019-04-18
WO2019073127A3 (en) 2019-08-22

Similar Documents

Publication Publication Date Title
SV2017005426A (en) DERIVATIVES OF PHENILTRIAZOL REPLACED WITH HYDROXIALQUIL AND ITS USES
SV2018005771A (en) PIRIDINILTRIAZOL DERIVATIVES REPLACED WITH AMIDA AND USES OF THESE
BR112018076601A2 (en) oral pharmaceutical formulation, methods for treating a patient, and use of a formulation
GT200900096A (en) DOSAGE FORMS OF PALONOSETRON CHLORHYDRATE THAT HAVE IMPROVED STABILITY AND BIODISPONIBILITY
MA45562A (en) STABLE LIQUID PHARMACEUTICAL PREPARATION
MA46334A (en) LIQUID PHARMACEUTICAL COMPOSITION
CO2020005768A2 (en) Phytoconcentrated composition and its uses
UY37221A (en) FENILTRIAZOL DERIVATIVES REPLACED WITH AMIDA AND USES OF THESE
IL253237A0 (en) Use in one pill / tablet / capsule minocycline, acicloguanosin, atorvastatin and vitamin d in the treatment of rheumatoid arthritis
CL2018003502A1 (en) Methods to treat heterotopic ossification.
MX2018000546A (en) Pharmaceutical composition containing celecoxib and tramadol.
GT201700007A (en) FORMULATION IN THE FORM OF A TABLET OF 2-FLUOR-N-METHYL-4- [7- (QUINOLIN-6-YLMETIL) IMIDAZO [1,2-B] [1,2,4] TRIAZIN-2-IL] BENZAMIDA
CL2019000563S1 (en) Packaging and dispensing of medicines. (divisional application 201800718)
PL3102187T3 (en) Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets
CO2018002428A2 (en) Selected amide of gamma-hydroxyiburic acid and uses thereof in the treatment of alcohol abuse
UY31662A1 (en) COMPOSITIONS OF RANITIDINE TABLETS OF ORAL DISINTEGRATION AND ITS METHODS OF ELABORATION.
CR20190022A (en) Combination of a bcl-2 inhibitor and a mcl-1 inhibitor, uses and pharmaceutical compositions thereof
IL250418A0 (en) Use in one pill / tablet / capsule minocycline, acicloguanosin, atorvastatin and vitamin d in the treatment of rheumatoid arthritis
CR20170125A (en) SOLID PHARMACEUTICAL COMPOSITION INCLUDING AMLODIPINA AND LOSARTÁN
IL263976A (en) Pharmaceutical composition containing combination of memantine and melatonin
BR112017013886A2 (en) product for oral delivery
CL2018002765A1 (en) Production process of solid mesalazine formulations.
PT3246058T (en) Device for the preparation and administration of liquid substances, particularly antiblastic chemotherapy drugs
CL2017000026A1 (en) Pharmaceutical dosage forms
MX2020004546A (en) Alcohol-resistant oral pharmaceutical compositions of lorazepam.